A review of the narrow-band ultraviolet B (NB-UVB) treatment outcomes of 117 patients with vitiligo, pruritus and other inflammatory dermatoses was conducted by researchers at Henry Ford Health System, Detroit.
Tracee Blackburn, PA-C: Gut Health for Healthy Skin
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment
QUIZ RECAP: Test Your Knowledge of Rosacea Complications and Comorbidities
ReV Up Your Vitiligo Treatment Strategies
Brittany Scurto, PA-C: How to Discuss an Integrative Medicine Approach With Patients
Introducing Omar Noor, MD, FAAD: Dermatology Times' Newest Editorial Advisory Board Member